August 02, 2019
Biopharmaceutical company Incyte Corp. sued newer rival Incysus Therapeutics Inc. in Delaware federal court on Thursday for allegedly infringing its trademarks by using a similar name and logo design that, Incyte claims, gives a "confusingly" and nearly identical commercial impression.